QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428

Part of paid clinical trials in Richmond, Virginia.

Sponsor
Veterans Recovery Network Inc.
Study ID
NCT07661823
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • ADHD
  • ADHD - Attention Deficit Disorder With Hyperactivity
  • ASD
  • Abstinence, Sex
  • Addiction Disorders
  • Alcohol Abuse/Dependence
  • Alcohol Addiction
  • Alcohol and Other Drug Use Disorders
  • Alcohol and Other Substance Use Prevention
  • Anger Problems
  • Asperger Disorder
  • Asperger's Disorder
  • Autism
  • Autism Disorder
  • Child Abuse, Sexual
  • Cocaine Abuse
  • Eating Behavior Disorders
  • Gambling Addiction
  • Gambling Disorder
  • Gender Dysphoria, Adult
  • Homeless and Low Incomes People, Refugees
  • Homelessness
  • MDMA ('Ecstasy')
  • Marijuana Abuse and Dependence
  • Marijuana Use Disorder
  • Narcissism
  • Narcotic Addiction
  • Narcotic-Related Disorders
  • Opiate Substitution Treatment
  • Opioid Abuse (Disorder)
  • Opioid Abuse and Addiction
  • Psychedelic Drug Dependence
  • Psychedelic Effects in Healthy Volunteers
  • Psychedelic Experiences
  • Psychiatric Disorder
  • Reliability and Validity
  • Sex Abuse
  • Sex Behavior
  • Sex Crimes
  • Sex Disorder
  • Sex Disorders
  • Smoking (Tobacco) Addiction
  • Smoking Abstinence
  • Smoking Among Youth

Eligibility Criteria

Sex
ALL
Age
17 Years - 99 Years
Healthy Volunteers
Accepted

Interventions

  • AI City Hall Project (AIhealth4u - Public Health Central) — BEHAVIORAL
    QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation)
  • AI City Hall Project (QAIAx Microcity A - AI Public Health Central) — BEHAVIORAL
    QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)

Study Details

BRIEF SUMMARY A. "What is the purpose of this study?" This study will test whether the "AI City Hall Project" (QAIAx), a quantum artificial intelligence (AI) public health agency, can provide free or low-cost behavioral and mental health services inside self-contained, dome-enclosed communities called "Microcities". Researchers want to see if AI-managed public administration, AI humanoid robots, holoportation of human-figures via 'holo-suites' (e.g., AI-119 Kikkeri Holo-Suit; AI-119 Vulcan QM-Ware) and advanced AI mental-health tools can lower housing and care costs, improve mental health outcomes (e.g., particular ecosystems using AI tools among persons with one or more addiction disorders), and be financially sustainable for people on fixed incomes or public assistance. B. "What conditions does the study focus on?" The study focuses on adults with: * Autism spectrum disorders (Asperger's, autism, ADHD, ASD) * Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine) * Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders) * Behavioral addictions (gambling, sex addiction) and related issues (sex offence history). C. "What does the study involve?" Eligible volunteers live in an omni AI-managed Microcity for up to 24 months. The community is housed in a geodesic dome that contains all daily necessities: housing, food, utilities, healthcare, and public services. Daily life is managed by an AI system (ISAC) and AI humanoid robots, with only occasional human oversight. Participants receive free mental-health treatment that may include AI-driven counselling, virtual-reality therapy (holo-suits), and non-invasive digital "attitude inoculation" protocols designed to reduce stress and addiction cravings. All participants also take AI-technology courses as a condition of enrolment. The study does not use any FDA-regulated drug, device, or biologic. \*\*Who can participate?\*\* You may be able to join if you: * Are an adult (18 years or older) * Have a diagnosis of one of the listed mental-health or addiction disorders * Are referred by a licensed health professional (e.g., RN, NP, PhD, MD), a non-profit organisation (e.g., 501(c)(3), university, church), or a public agency (e.g., case manager, social worker, parole/probation officer, judge) * Are willing to live in a closed, AI-managed community for up to one year and complete AI educational courses. Participants who are veterans, receive public assistance (e.g., VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritised. \*\*Where is the study taking place?\*\* The study will be conducted at Microcity sites in the United States and internationally. The first administrative site is in Richmond, Virginia, USA. Additional sites are planned in partner nations, including tribal lands, military installations, and special economic zones. \*\*Who is sponsoring the study?\*\* The study is sponsored by \*\*Veterans Recovery Network Inc.\*\*, a non-profit organization, in collaboration with \*\*AI-119 Vulcan Project Research \& Educational Technology Co. (PRETCO)\*\* and an AI legal agency. The study is conducted under U.S. federal research and development authorities (28 U.S.C. §1498; 10 U.S.C. §129a) and is part of a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command (USSOCOM). This summary describes a planned clinical study. Not all details may be final. Information may change as the study progresses.

Key Dates

Start date
Aug 1, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
1,000,000 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: AI Public Health Central (Group 1)
  • Experimental: AI Public Health Central (Group 2)
  • Experimental: AI Public Health Central (Group 3)
  • Experimental: AI Public Health Central (Group 4)
  • Experimental: AI Public Health Central (Group 5)
  • Experimental: AI Public Health Central (Group 6)
  • Experimental: AI Public Health Central (Group 7)
  • Experimental: AI Public Health Central (Group 8)
  • Experimental: AI Public Health Central (Group 9)
  • Experimental: AI Public Health Central (Group 10)
  • Experimental: AI Public Health Central (Group 11)

Primary Outcome Measure

Vulcan QAIAx v4.0x (Beta ISAC) for AI-119 and AI Wat (1498) patent series for Private, Public, and Military sectors (Change from Baseline in Participant Lifestyle Efficiency, Behavioral Stability, & Sovereign Resource Allocation via Vulcan QAIAx v4.0) [ Time Frame: Baseline enrollment, month 12, and month 24 (tracked monthly) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Administrative OfficeRichmondVirginia23219-

Find similar trials in Richmond, VA

Related Studies